(Q44993846)

8 December 2017

0 references

1 reference

title

Antiproliferative drug-eluting stents: systematic review of the benefits and estimate of economic impact (English)

1 reference

8 December 2017

Gloria Oliva

1

1 reference

8 December 2017

Mireia Espallargues

series ordinal

2

1 reference

8 December 2017

Juan M V Pons

series ordinal

3

1 reference

8 December 2017

language of work or name

Spanish

0 references

publication date

1 July 2004

1 reference

Revista Española de Cardiología

8 December 2017

published in

1 reference

8 December 2017

volume

57

1 reference

8 December 2017

issue

7

1 reference

8 December 2017

page(s)

617-628

1 reference

ABC of interventional cardiology: percutaneous coronary intervention. I: history and development

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

New approaches to preventing restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

A paclitaxel-eluting stent for the prevention of coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Initial results of the Quanam drug eluting stent (QuaDS-QP-2) Registry (BARDDS) in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977162-6

7 January 2021

10.1016/S0300-8932(04)77162-6

Identifiers

DOI

1 reference

8 December 2017

1 reference